Breast cancer (BrCa) is the most common malignancy in women and the second most
significant cause of death from cancer. BrCa is one of the most challenging malignancies to …

OBJECTIVE Available evidence supports the emerging hypothesis that metabolic syndrome
may be associated with the risk of some common cancers. We did a systematic review and …

Purpose Metabolic syndrome is associated with an increased risk of cardiovascular disease,
type 2 diabetes, and breast cancer recurrence in survivors of breast cancer. This …

Hypercholesterolemia is a risk factor for estrogen receptor (ER)–positive breast cancers and
is associated with a decreased response of tumors to endocrine therapies. Here, we show …

Obesity is a leading modifiable risk factor for the development of several epithelial
malignancies. In addition to increasing risk, obesity also confers worse prognosis for many …

Cholesterol is a risk factor for breast cancer although the mechanisms by which this occurs
are not well understood. One hypothesis is that dyslipidemia results in increased cholesterol …

Two risk factors for the development and progression of cancers that are amenable to life
style modification are chronic inflammation and the metabolic syndrome. This review …

Objective The role of metabolic syndrome (MS) and its individual components in
postmenopausal breast cancer (PBC) risk is still unclear. We reviewed and summarized …

Purpose Epidemiologic studies exploring causal associations between serum lipids and
breast cancer risk have reported contradictory results. We conducted a meta-analysis of …

Metabolic syndrome (MS), conventionally defined by the presence of at least three out of five
dysmetabolic traits (abdominal obesity, hypertension, low plasma HDL-cholesterol, high …